Avocado and Soy Supplementation for Knee Osteoarthritis .
This report has been verified
by one or more authors of the
original publication.
Joint Dysfunctionality Alleviation along with Systemic Inflammation Reduction Following Arthrocen Treatment in Patients with Knee Osteoarthritis: A Randomized Double-Blind Placebo-Controlled Clinical Trial
Medicina (Kaunas). 2022 Feb 2;58(2): 228.119 patients with mild/moderate knee osteoarthritis were randomized to receive Arthrocen capsules, an avocado/soy supplement, or a placebo. Outcomes of interest included the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), the Short-Form 20 (SF-20) quality of life questionnaire, Lequesne scores, pain on a Visual Analog Scale, joint tenderness, patella crepitus, joint shrug sign, and inflammatory markers (tumour necrosis factor-alpha [TNF-a]; interleukin [IL] 17, IL 10, IL 4). Outcomes were assessed after 3 months of follow-up, and at 3 and 6 months of follow-up for inflammatory markers. Arthrocen reduced joint tenderness and lowered all inflammatory marker levels vs. placebo.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
